Satin Creditcare Q2 Profit Hits Rs 171 Crore; Promoters Infuse Capital

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Satin Creditcare Q2 Profit Hits Rs 171 Crore; Promoters Infuse Capital

Satin Creditcare Network reported a standalone net profit of Rs 171.61 crore for Q2 FY27 with revenue reaching Rs 811.52 crore. The company also announced a preferential allotment of 38.5 lakh convertible warrants to the promoter group and injected Rs 122 crore of capital into its subsidiaries, Satin Finserv and Satin Growth Alternatives.

Satin Creditcare Reports Strong Q2 FY27 Performance and Capital Infusion

Standalone Net Profit: Rs 171.61 crore
Revenue from Operations: Rs 811.52 crore

Reader Takeaway: Steady profit growth paired with promoter confidence via warrant allotment signals stable capital planning for future expansion.

What just happened

Satin Creditcare Network reported its financial results for the quarter ended September 30, 2026. The company posted a standalone net profit of Rs 171.61 crore on revenues of Rs 811.52 crore. On a consolidated basis, the firm clocked a net profit of Rs 175.90 crore with a total income of Rs 929.23 crore. Statutory auditors J C Bhalla & Co. issued an unmodified opinion on the results.

Why this matters

The company is aggressively funding its growth engines. It injected Rs 110 crore into its wholly-owned subsidiary, Satin Finserv Limited, and Rs 12 crore into Satin Growth Alternatives Limited via rights issues. Simultaneously, the promoter group entity, Trishashna Holdings & Investments, is backing the company through the subscription of 38,50,000 fully convertible warrants, with 25% of the capital already received.

What changes now

The issuance of warrants to the promoter group strengthens the balance sheet and signals long-term commitment. Shareholders should note that the conversion of these warrants will eventually expand the company’s equity base. The capital injection into subsidiaries suggests that management is prioritizing the scaling of its lending and growth-alternatives businesses.

Risks to watch

Investors should closely monitor the asset quality and the deployment efficiency of the Rs 122 crore capital infusion in subsidiaries. As a microfinance and lending-focused entity, any volatility in credit repayment cycles remains a standard risk factor.

Context metrics

The company confirmed that all outstanding secured non-convertible debentures remain fully backed by book debts and loan receivables, maintaining the required asset cover for debt holders.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.